Masimo Corporation (MASI) is a leading innovator in non-invasive monitoring solutions, based in Irvine, California, with a mission to enhance patient care and improve clinical outcomes across global healthcare systems. The company's advanced technologies, including its proprietary pulse oximetry and non-invasive biometrics, play a crucial role in modern healthcare settings, thereby driving efficiencies and enhanced monitoring capabilities. As Masimo continues to expand its product offerings, it remains well-positioned to address the evolving challenges of the healthcare landscape, making it a compelling investment opportunity for institutional stakeholders.